Evaluation of Carboplatin/Paclitaxel/Bevacizumab in the Treatment of Advanced Stage Endometrial Carcinoma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Genentech
Information provided by (Responsible Party):
David O'Malley, The Ohio State University
ClinicalTrials.gov Identifier:
NCT00513786
First received: August 8, 2007
Last updated: May 3, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2012
  Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)